Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases

doi:10.3748/wjg.v19.i46.8552

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10335)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

724

HTML

7073

Figures (1-2)

258

Tables (1-1)

181

Sum=8236

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1179

Download

920

Sum=2099

Dec 14, 2013 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 14, 2013; 19(46): 8552-8561
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8552

Full Size Figure Download Figure

Figure 1 Macronutrients and micronutrients essential for the recovery and maintenance of nutritional status in cystic fibrosis patients[7]. MCT: Medium chain triglycerides.

Citation: Haack A, Aragão GG, Novaes MRCG. Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. World J Gastroenterol 2013; 19(46): 8552-8561
URL: https://www.wjgnet.com/1007-9327/full/v19/i46/8552.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i46.8552